Drug: Lexapro (Escitalopram)

/ Blogs / By

Drug: Lexapro (Escitalopram)

  • Drug pharmacology, pharmacokinetics
  • Brand name
  • Generic name
  • Dosing
  • Indications for use
  • Side effects
  • Contraindications
  • Pregnancy class
  • You must also perform a cost analysis of the drug.
  • Provide a patient case study on a patient in which you would utilize the drug you have selected and include at least two peer-reviewed evidence-based studies related to the drug.
  • Describe the appropriate patient education.
  • What is your role as a Nurse Practitioner for prescribing this medication to this patient on your case study presentation?
  • Describe the monitoring and follow-up.

Drug: Lexapro (Escitalopram)

Lexapro (Escitalopram) Overview

Generic Name:

  • Escitalopram

Brand Name:

  • Lexapro

Pharmacology:

Escitalopram is a selective serotonin reuptake inhibitor (SSRI) that works by increasing the levels of serotonin in the brain, which helps improve mood.

Pharmacokinetics:

  • Absorption: Well absorbed after oral administration, with peak plasma concentrations occurring approximately 5 hours post-dose.
  • Distribution: Widely distributed throughout the body, with a volume of distribution of about 12-26 L/kg. Approximately 56% bound to plasma proteins.
  • Metabolism: Metabolized in the liver via the cytochrome P450 system, primarily by CYP3A4 and CYP2C19 enzymes.
  • Elimination: Excreted primarily through urine (approximately 8% unchanged) and feces. The elimination half-life is about 27-32 hours.

Dosing:

  • Adults: Typically starts at 10 mg once daily, may be increased to a maximum of 20 mg daily depending on the clinical response.
  • Elderly/Patients with hepatic impairment: Initial dose of 5 mg once daily, with a cautious increase.

Indications for Use:

  • Major depressive disorder (MDD)
  • Generalized anxiety disorder (GAD)

Side Effects:

  • Common: Nausea, insomnia, fatigue, dry mouth, increased sweating, somnolence, dizziness, and sexual dysfunction.
  • Serious: Serotonin syndrome, hyponatremia, increased risk of bleeding, seizures, and QT prolongation.

Contraindications:

  • Concurrent use with monoamine oxidase inhibitors (MAOIs) or within 14 days of stopping an MAOI.
  • Known hypersensitivity to escitalopram or any of its components.

Pregnancy Class:

  • Category C: Risk cannot be ruled out. Should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.

Cost Analysis:

  • Brand (Lexapro): Approximately $450-$500 for a 30-day supply (10 mg tablets).
  • Generic (Escitalopram): Approximately $10-$30 for a 30-day supply (10 mg tablets).

Case Study:

Patient Profile:

  • Name: Jane Doe
  • Age: 35 years
  • Gender: Female
  • Diagnosis: Major Depressive Disorder (MDD)
  • Medical History: No significant medical history, non-smoker, moderate alcohol use.
  • Current Medications: None
  • Symptoms: Persistent sadness, lack of interest in daily activities, fatigue, insomnia, and difficulty concentrating for the past six months.

Treatment Plan:

  • Medication: Escitalopram 10 mg once daily.
  • Rationale: Chosen due to its efficacy in treating MDD and relatively favorable side effect profile.
  • Peer-reviewed Evidence:
    • Study 1: Montgomery et al. (2001) demonstrated the efficacy of escitalopram in treating major depressive disorder with a favorable side effect profile.
    • Study 2: Baldwin et al. (2016) found escitalopram to be effective and well-tolerated in the long-term treatment of generalized anxiety disorder, which often co-occurs with depression.

Patient Education:

  • Medication Instructions: Take once daily at the same time each day, with or without food.
  • Potential Side Effects: Discuss common and serious side effects. Advise to report any unusual symptoms, especially those indicating serotonin syndrome or worsening depression/suicidal thoughts.
  • Lifestyle Modifications: Encourage regular exercise, healthy diet, and adherence to therapy sessions.
  • Pregnancy: Discuss potential risks if planning to become pregnant or if pregnant.

Role as a Nurse Practitioner:

  • Assessment: Comprehensive evaluation of the patient’s psychiatric and medical history.
  • Diagnosis: Confirm diagnosis of MDD based on clinical criteria.
  • Treatment Plan: Initiate escitalopram therapy and provide education.
  • Monitoring: Regular follow-up to assess efficacy, side effects, and adherence.
  • Collaboration: Work with a multidisciplinary team if necessary (e.g., psychiatrists, therapists).

Monitoring and Follow-up:

  • Initial Follow-up: 2-4 weeks after starting medication to assess response and side effects.
  • Subsequent Visits: Every 4-6 weeks until stable, then every 3-6 months.
  • Monitoring Parameters:
    • Mental status exam
    • Side effects review
    • Vital signs (blood pressure, heart rate)
    • Electrolytes (especially sodium in elderly patients)
    • QT interval (if indicated)

Regular follow-up visits and communication with the patient are essential to ensure the efficacy and safety of the treatment plan.

Scroll to Top